29023-36-7 Usage
Use
Pharmaceutical compound used to treat seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy.
Mechanism of Action
Modulates the activity of sodium channels in the brain, reducing the occurrence and severity of seizures.
Classification
Sulfonamide derivative, anticonvulsant medication.
Available Forms
Tablet and oral suspension.
Administration
Typically taken in combination with other seizure medications.
Common Side Effects
Dizziness, fatigue, and nausea.
Precaution
Important to use under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 29023-36-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,0,2 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 29023-36:
(7*2)+(6*9)+(5*0)+(4*2)+(3*3)+(2*3)+(1*6)=97
97 % 10 = 7
So 29023-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H11Cl2NS2/c1-13(2)10(14)15-6-7-3-4-8(11)9(12)5-7/h3-5H,6H2,1-2H3
